Developing new drugs to treat human disease is an expensive, complex and time-consuming process. Bringing a new drug to market can take up to 15 years and costs $2.5 billion or more.
Our biopharmaceutical and biotech customers have trusted us to help them advance their trials. Our therapeutic area expertise spans large drug disease markets such as hematology/oncology and chronic conditions along with growing areas of R&D innovation, such as immuno-oncology, cell and gene therapy, biomarkers and rare diseases.
At every stage of the drug development process, PPD deploys the expertise you need to design, plan and execute your clinical trials with skill, precision and unwavering focus on quality.
Explore our therapeutic area experience below to learn how PPD can advance your drug development program
ppd’s experience in the past five years supporting